Latest Module
Does insulin have a role in type 2 diabetes mellitus in 2026?
This clinical update by Dr Elmo Pretorius, Specialist physician and endocrinologist addresses the use of insulin in T2DM patients who are being treated with cardiorenal-safe therapies
Making sense of SGLT-2 inhibitors in daily practice – 2026 Clinical update of CRM therapy
Prof Zaheer Bayat, Endocrinologist, Johannesburg, guides clinicians on effective early use of SGLT-2i in daily practice
What is new? Advanced Technologies and Treatment for Diabetes (ATTD)
Interpreting advances in AI, diabetes screening, hypoglycaemic unawareness and glycaemic risk in the care T1 & T2DM patients


